The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,821,706 in first-year total cost, median $348,710.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-A (52)]6
- Special Emphasis Panel[ZRG1 AARR-N (53)]5
Most frequent institutions
- UNIVERSITY OF CAPE TOWN5
- WITS HEALTH CONSORTIUM (PTY), LTD3
- CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA2
- STELLENBOSCH UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Novel predictors of survival among breast cancer patients with/without HIV in South Africa1R01CA250012-01 | CUBASCH, HERBERTEL-SADR, WAFAA M.JACOBSON, JUDITH SJOFFE, MAUREENNEUGUT, ALFRED I.RUFF, PAUL | WITS HEALTH CONSORTIUM (PTY), LTD | $349,996 | ZRG1 |
| 2020 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN1R01HD102050-01 | GRAY, CLIVE MAURICEJASPAN, HEATHER BERYL | UNIVERSITY OF CAPE TOWN | $349,990 | ZRG1 |
| 2020 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)1R01AI152183-01 | MEINTJES, GRAEME AYTONPHILLIPS, ELIZABETH | UNIVERSITY OF CAPE TOWN | $349,915 | ZRG1 |
| 2020 | Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.1R01AI152118-01 | HAPGOOD, JANET PATRICIAMORRISON, CHARLES | UNIVERSITY OF CAPE TOWN | $349,856 | ZRG1 |
| 2020 | The South African National HIV Pregnancy Cohort: evaluating continuity of care among women living with HIV1R01HD103466-01 | CLOUSE, KATEMASKEW, MHAIRI | WITS HEALTH CONSORTIUM (PTY), LTD | $348,982 | ZRG1 |
| 2020 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa1R01AI152115-01 | GILBERT, PETER B.WILLIAMSON, CAROLYN | UNIVERSITY OF CAPE TOWN | $348,710 | ZRG1 |
| 2020 | Evaluating UTT with a National HIV Cohort to Optimize South Africa's HIV Response (ENCORE)1R01AI152149-01 | BOR, JACOBONOYA, DORINA | WITS HEALTH CONSORTIUM (PTY), LTD | $348,064 | ZRG1 |
| 2020 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women1R01CA250011-01 | DENNY, LYNETTEKUHN, LOUISE | UNIVERSITY OF CAPE TOWN | $347,008 | ZRG1 |
| 2020 | Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa1R01AI152142-01 | DOOLEY, KELLY E.NAIDOO, ANUSHKA | CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA | $346,580 | ZRG1 |
| 2020 | Urine tenofovir point-of-care test to identify patients in need of ART adherence support1R01AI152119-01 | GANDHI, MONICAORRELL, CATHERINEVAN ZYL, GERT UVES | STELLENBOSCH UNIVERSITY | $343,464 | ZRG1 |
| 2020 | Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health1R01HD102052-01 | JASPAN, HEATHER BERYLNGCAPU, SINAYE | CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA | $339,141 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.